Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC)

Annals of Oncology

Volumn 17, Issue SUPPL. 5, 2006, Pages

  Santo, Antonio ^a,b,d   Genestreti, G ^a,b   Sava, T ^b   Manno, P ^b   Terzi, A ^a,c   Molino, A M ^b   Cetto, G L ^b  

^a GIVOP (Gruppo Interdisciplinare Veronese di Oncologia Polmonare)   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Verona Hospital   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; MITOMYCIN C; NAVELBINE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; VINBLASTINE; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RELAPSE; CLINICAL TRIAL; DRUG TOLERABILITY; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY;

EID: 33745604289     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj951     Document Type: Article

References (40)

1. Ginsberg RJ, Vokes EE, Raben A. Non-small cell lung cancer. In: VT De Vita Jr, Hellman S, Rosemberg SA (eds), Cancer: Principles and Practice. Lippincott-Raven, Philadelphia, PA, 1997, pp 858-911.
2. Johnson DH, Turrisi AT, Pass AJ. Combined modality treatment for locally advanced non-small cell lung cancer. In: HJ Pass, J Mitchell, DH Johnson, AT Turrisi (eds), Lung Cancer: Principles and Practice. Lippincott-Raven, Philadelphia, PA, 1996, pp 863-873.
3. Mountain CF. Revisions in the International system for staging lung cancer. Chest 1997; 111: 1710-1717.
4. Corey JL. Induction or neo-adjuvant therapy in resectable non-small cell lung cancer. Sem Oncol 1999; 26 (suppl. 5): 34-39.
5. Spain R. Neo-adjuvant Mitomicin-C, cisplatin and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: Problems and progress from the perspective of long term follow-up. Semin Oncol 1998; 15: 6-15.
6. Martini N, Kris MG, Flehinger BJ et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55: 1365-1373.
7. Sugarbaker DJ, Herndon J, Kohman LJ et al. Results of cancer and leukemia group B protocol 8935. A multiistitutional phase II trimodality trial for stage IIIA (N2) non-small cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg 1995; 109: 473-483.
8. Darwish S, Minotti V, Crinò L et al. A phase II trial of combined chemotherapy and surgery in stage IIIA non-small cell lung cancer. Lung Cancer 1995; 12: 71-78.
9. Burkes RL, Ginsberg RJ, Shepherd FA et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small cell lung cancer: Results of the Toronto Phase II Trial. J Clin Oncol 1992; 10: 1927-1932.
10. Elias AD, Skarin AT, Leong T et al. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer 1997; 17: 147-161.
11. Weiden PL, Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: A phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991; 83: 266-273.
12. Strauss GM, Herndon JE, Sherman DD et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell lung carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10: 1237-1244.
13. Albain KS, Rusch VW, Crowley JJ et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13: 1880-1892.
14. Choi NC, Carey RW, Daly W et al. Potential Impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol 1997; 15: 712-722.
15. Eberhardt W, Wilke H, Stamatis M et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced Non-small cell lung cancer. Mature results of a phase II study. J Clin Oncol 1998; 16: 622-634.
16. Pass HI, Pogrebniak HW, Steinberg SM et al. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg 1992; 53: 992-998.
17. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA NSCLC. J Natl Cancer Inst 1994; 86: 673-680.
18. Rosell R, Gomez-Codina J, Camps C et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in patients with non-small cell lung cancer. N Eng J Med 1994; 330: 153-158.
19. Depierre A, Milleron B, Moro-Sibilot D et al. Phase III trial of neo-adjuvant chemotherapy (NCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC): The Franch Experience. Proc Am Soc Clin Oncol 1999; 18: (Abstr. 1792).
20. Depierre A, Milleron B, Moro-Sibilot D et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small cell lung cancer. J Clin Oncoll 2002; 20: 247-253.
21. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small cell lung cancer (NSCLC). Ann Oncol 2005; 16 (Suppl. 1): I28-i29.
22. Pisters KM, Ginsberg RJ, Giroux DJ et al. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team (BLOT). J Thorac Cadiovasc Surg 2000; 119: 429-439.
23. O'Brien ME, Splinter T, Smit EF et al. Carboplatin and paclitaxel (Taxol) as an induction regimen for patients with biopsy-proven stage IIIAN2 non-small cell lung cancer. An EORTC phase II study (EORTC 08958). Eur J Cancer 2003; 39: 1416-1422.
24. Betticher DC, Somitz SH, Totsch M et al. Mediastinal lymph node clearance after docetaxel-cisplatin neo-adjuvant chemotherapy is prognostic of survival in patients with stage IIIApN2 non-small cell lung cancer: A muticenter phase II trial. J Clin Oncol 2003; 21: 1752-1759.
25. Van Zandwijk N, Smit EF, Kramer GW et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cooperative Group (EORTC 08955). J Clin Oncol 2000; 18: 2658-2664.
26. Yang CH, Tsai CM, Wang LS et al. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. Br J Cancer 2002; 86: 190-196.
27. Crinò L, Betti M, Gregorc V et al. Induction chemotherapy with gemcitabine and cisplatin in locally advanced stage III non-small cell lung cancer. A phase II study. Proc Am Soc Clin Oncol 1999; 18: (Abstr. 1883).
28. Rubio I, Abòn G, Muñoz A et al. Preoperative chemotherapy (CHT) with cisplatin and gemcitabine in locally advanced (LA) unresectable non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000; 19: (Abstr. 2122).
29. Migliorino MR, De Marinis F, Nelli F et al. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for stage III non-small cell lung cancer. Lung Cancer 2002; 35: 319-327.
30. Santo A, Pedersini R, Terzi A et al. Neo-adjuvant chemotherapy with gemcitabine (g) and cisplatin in stage IIIAN2/IIIB non-small cell lung cancer (NSCLC). A multicenter phase II study with a 21 days schedule: final results. Proc Am Soc Clin Oncol 2003; 22: (Abstr. 2669).
31. Cappuzzo F, Selvaggi G, Gregorc V et al. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable stage IIIA-bulky N2 and stage IIIB non-small cell lung carcinoma: An Italian Lung Cancer Project Observational Study. Cancer 2003; 98: 128-134.
32. Pisters K, Vallieres E, Bunn P et al. S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/ carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Proc Am Soc Clin Oncol 2005; 23: (Abstr. 7012).
33. Scagliotti GV. Preliminary results of Ch.E.S.T.: A phase III study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2005; 23: (Abstr. LBA7023).
34. Mattson KV, ten Velde G, Krofta K et al. Taxotere as neo-adjuvant therapy for radically treatable stage III NSCLC. Preliminary results of an international phase III study. Proc Am Soc Clin Oncol 2000; 19: (Abstr. 1890).
35. Mattson KV, Abratt RP, ten Velde G et al. Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: A multinational randomized phase III study. Ann Oncol 2003; 14: 116-122.
36. Rusch V, Albain K, Turrisi A et al. Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa (pN2) non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American intergroup 0139 (RTOG 9309). 11th World Conference on Lung Cancer: 03-06 July 2005, Barcelona, Spain. Lung Cancer 2005; 49 (Suppl. 2) S15: (Abstr. 0-035).
37. Van Meerbeeck J, Van Schil P, Kramer G et al. A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941). 11th World Conference on Lung Cancer: 03-06 July 2005, Barcelona, Spain. Lung Cancer 2005; 49 (suppl. 2) S4: (Abstr. Pr5).
38. De Leyn P, Stroobants S, Vanteenkiste J et al. Prospective study of accuracy of redo videomediastinoscopy and PET-CT in detecting residual mediastinal disease after induction chemotherapy for NSCLC. 11th World Conference on Lung Cancer: 03-06 July 2005, Barcelona, Spain. Lung Cancer 2005; 49 (suppl. 2) S3: (Abstr. Pr2).
39. Winton TL, Livingston R, Johnson D et al. A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non-small cell lung cancer (NSCLC) Intergroup JBR.10. Proc Am Soc Clin Oncol 2004; 22: (Abstr. 7018).
40. Strauss GM, Emdon J, Maddaus MA et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. Proc Am Soc Clin Oncol 2004; 22: (Abstr. 7019).